跳至主要内容
临床试验/NCT02076438
NCT02076438终止不适用

Probiotics for Prevention of Antibiotic Associated Diarrhea and Clostridium Difficile Associated Disease in Hospitalized Adults-A Double Blind Placebo Controlled Trial

Rutgers, The State University of New Jersey2 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2015年11月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
110
试验地点
2
主要终点
Diarrhea

研究概览

简要总结

The study will evaluate if administration of probiotic Culturelle (Lactobacillus Rhamnosus GG) along with antibiotics can help decrease the occurrence of diarrhea caused by antibiotics as well as Clostridium difficile Diarrhea.

详细描述

Inpatient adult males and females who are at least 18 years of age or older, undergoing treatment with antibiotics irrespective of indication and the type of antibiotics. The setting is an academic hospital.The patients are screened and potentially recruited upon initiation of antibiotic treatment regardless of indication for antibiotic prescription. The participants are patients being admitted to any inpatient units of the hospital for treatment with antibiotics. Exclusion criteria is:

  • Diarrhea on admission or within the preceding week
  • Reported recurrent diarrhea
  • Bowel pathology that could result in diarrhea (including preexisting Inflammatory Bowel disease{IBD}, all forms for colitis or any other condition resulting in preexisting diarrhea)
  • Intake of high risk antibiotics (clindamycin, cephalosporins, aminopenicillins→ well known to cause CDAD) and or more than two courses of other antibiotics in the past four weeks to exclude pre-existing diarrhea associated with antibiotic use
  • Immunosuppression (Chronic steroid use, Active chemotherapy, Active radiotherapy, HIV or any other disorder resulting in a compromise in participants immune status)
  • Bowel surgery causing liquid stools
  • Regular probiotic intake before admission
  • Lactose intolerance or intolerance to dairy products.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inpatient adult males and females who are at least 18-89 years of age, undergoing treatment with antibiotics irrespective of indication and the type of antibiotics.

排除标准

  • Diarrhea on admission or within the preceding week
  • Reported recurrent diarrhea
  • Bowel pathology that could result in diarrhea (including preexisting Inflammatory Bowel disease{IBD}, all forms for colitis or any other condition resulting in preexisting diarrhea)
  • Intake of high risk antibiotics (clindamycin, cephalosporins, aminopenicillins→ well known to cause CDAD) and or more than two courses of other antibiotics in the past four weeks to exclude pre-existing diarrhea associated with antibiotic use
  • Immunosuppression (Chronic steroid use, Active chemotherapy, Active radiotherapy, HIV or any other disorder resulting in a compromise in participants immune status)
  • Bowel surgery causing liquid stools
  • Regular probiotic intake before admission
  • Lactose intolerance or intolerance to dairy products

结局指标

主要结局

Diarrhea

时间窗: 4 weeks

Diarrhea associated with antibiotics

次要结局

  • Tolerability of probiotics(4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amita Avadhani, DNP, DCC, ACNP, ANP, CCRN

Assistant Professor/Director Post MSN-DNP program

Rutgers, The State University of New Jersey

研究点 (2)

Loading locations...

相似试验